Journal of Alzheimer s Disease · 2018 · 17 citations · 36 references
MedicineNeurologyPathologyNeurodegenerationNeurogeneticsNeuropathologyFrontotemporal DementiaGenetic DisordersHereditary NeuropathiesNeurodegenerative DiseasesNeurodegenerative DisordersNeurogenetic DisordersFamilial DementiaFamilial Neurodegenerative DiseaseGenetic NeurodegenerationNeurodegeneration GeneticsNeurodegenerative GeneticsNeuropathological ClassificationNeuropathological ExaminationTauopathy Genetics
Frontotemporal lobar degeneration (FTLD) is a clinically, pathologically, and genetically heterogeneous group of disorders that affect the frontal and temporal lobes of the brain. FTLD classification distinguishes three main neuropathological groups: FTLD-tau, FTLD-TDP, and FTLD-FUS. As a four-repeat tauopathy, argyrophilic grain disease (AGD) is included in the FTLD-tau group. AGD may also appear in association with other neuropathological disorders. We describe the demographic, clinical, neuropathological, and genetic characteristics of a series of FTLD cases presenting with AGD. For this purpose, a clinico-pathological study of 71 autopsy-confirmed FTLD cases from different tissue banks was performed. AGD was found in 52.1% of FTLD cases. The presence of AGD increased with the increasing age (up to 88.9% in cases older than 80 years; p < 0.001) and was associated with higher ages at onset (p < 0.001) and death (p < 0.001). In AGD cases, progressive supranuclear palsy (PSP) was the most frequent clinical diagnosis (29.7%) and gait disturbance was the most common symptom (64.5%); behavioral and language symptoms were less frequent as compared with non-AGD cases (p = 0.055; p = 0.012). PSP was the most frequent neuropathological diagnosis among cases with AGD (32.4%). This group also showed less brain atrophy (p = 0.094) and higher prevalence of Alzheimer (p = 0.002) and vascular pathology (p = 0.047) as compared to the non-AGD group. We also observed that H1/H1 genotype was overrepresented in AGD cases (p = 0.018) and that there was no association with any specific APOE allele. A subanalysis of PSP cases according to the AGD status was carried out, yielding no significant differences.
36
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Suzanne S. Mirra, Albert Heyman, Daniel W. McKeel et al. · Neurology · 1991 · 5.1K citations
Thomas J. Montine, Creighton H. Phelps, Thomas G. Beach et al. · Acta Neuropathologica · 2011 · 2.9K citations · Full text
Medicine, Neurology, Neuroscience +16
Nigel J. Cairns, Eileen H. Bigio, Ian R. Mackenzie et al. · Acta Neuropathologica · 2007 · 1.1K citations · Full text
Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Mary V. Baker, Irene Litvan, Henry Houlden et al. · Human Molecular Genetics · 1999 · 794 citations · Full text
Life Sciences, Genetics, Neurology +12